Tina Dadu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Tina Dadu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Anil Handoo
Department of Hematology and Molecular Biology, BLK MAX Superspeciality Hospital, New Delhi, India
5 shared publications - Aditi Mittal
Hematology, BLK Super Speciality Hospital, Delhi, India
3 shared publications - Nishit Gupta
Hematology, BLK Super Speciality Hospital, Delhi, India
3 shared publications A. Gandhi
1 shared publication- Ankit Mittal
Department of Infectious Diseases, AIG Hospitals, Hyderabad, Telangana, India
1 shared publication - Nitin Gupta
Nuclear Medicine and PET/CT
1 shared publication
Latest Publications
- Open Access
- 11 November 2023
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 7, 100371
OC 15.2 ROTEM Versus Conventional Coagulation Parameter Based Correction of Coagulopathy in Upper Gastrointestinal Bleed in Cirrhotic Patients-Open Label Randomized Control Trial
- 11 November 2023
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 7, 100371
Open AccessOC 15.2 ROTEM Versus Conventional Coagulation Parameter Based Correction of Coagulopathy in Upper Gastrointestinal Bleed in Cirrhotic Patients-Open Label Randomized Control Trial
- 10 July 2023
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 40 (2) , 364-365
Contemporaneous Illustration of Megakaryopoiesis
- 10 July 2023
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 40 (2) , 364-365
Contemporaneous Illustration of Megakaryopoiesis
- 21 September 2020
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 37 (1) , 193-196
Loss of Normal Polyploid Spectrum as Marker of Clonality in Acute Megakaryoblastic Leukemia Evolving from Pre-Existing Primary Myelofibrosis
- 21 September 2020
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 37 (1) , 193-196
Loss of Normal Polyploid Spectrum as Marker of Clonality in Acute Megakaryoblastic Leukemia Evolving from Pre-Existing Primary Myelofibrosis
- 12 July 2020
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 36 (4) , 784-785
Unorthodox Flowcytometric Scatter and Severe Bone Marrow Fibrosis in De Novo Acute Promyelocytic Leukaemia
- 12 July 2020
- Published by Springer Nature in Indian Journal of Hematology and Blood Transfusion
- Vol. 36 (4) , 784-785
Unorthodox Flowcytometric Scatter and Severe Bone Marrow Fibrosis in De Novo Acute Promyelocytic Leukaemia
- Open Access
- 1 January 2018
- Published by Springer Nature in Indian Pediatrics
- Vol. 55 (1) , 55-62
Flow Cytometry in Pediatric Malignancies
The utility of flow cytometry as a useful diagnostic modality for the assessment of hematopoietic neoplasms has been established beyond doubt. In fact, it is now an integral part of the diagnosis and classification of various diseases like leukemias and lymphomas along with molecular studies and cytogenetics. Prognostication and disease monitoring by flow cytometry is also being recognized increasingly as one of the important fortes. This is evident by the number of articles in the published in literature on the minimal residual disease detection by flow cytometry especially in the last decade or so. To add to this, ever growing list of utilities in hematopoietic malignancies, many nonhematopoietic neoplasms can also be analyzed by flow cytometry. The examples include fluid specimens from serous cavity effusions and samples from solid tissues like lymph nodes, reticulo-endothelial tissue, central nervous system tissue, etc. Flow cytometry technique provides a unique blend of rapidity, high sensitivity and specificity compared to cyto-morphology and conventional immunohistochemical staining. It is also remarkable for simultaneous analysis of more than one marker on the cells. Evaluation of limited samples such as cerebrospinal fluid or fine needle aspiration samples makes Flow cytometry a valuable tool. DNA ploidy analysis and assessment of pediatric non-hematopoietic neoplasms by Flow cytometry has envisaged the utility vista of this technique. This review is aimed at providing an insight into the applications of flow cytometry in pediatric malignancies.
- 1 January 2018
- Published by Springer Nature in Indian Pediatrics
- Vol. 55 (1) , 55-62
Open AccessFlow Cytometry in Pediatric Malignancies
The utility of flow cytometry as a useful diagnostic modality for the assessment of hematopoietic neoplasms has been established beyond doubt. In fact, it is now an integral part of the diagnosis and classification of various diseases like leukemias and lymphomas along with molecular studies and cytogenetics. Prognostication and disease monitoring by flow cytometry is also being recognized increasingly as one of the important fortes. This is evident by the number of articles in the published in literature on the minimal residual disease detection by flow cytometry especially in the last decade or so. To add to this, ever growing list of utilities in hematopoietic malignancies, many nonhematopoietic neoplasms can also be analyzed by flow cytometry. The examples include fluid specimens from serous cavity effusions and samples from solid tissues like lymph nodes, reticulo-endothelial tissue, central nervous system tissue, etc. Flow cytometry technique provides a unique blend of rapidity, high sensitivity and specificity compared to cyto-morphology and conventional immunohistochemical staining. It is also remarkable for simultaneous analysis of more than one marker on the cells. Evaluation of limited samples such as cerebrospinal fluid or fine needle aspiration samples makes Flow cytometry a valuable tool. DNA ploidy analysis and assessment of pediatric non-hematopoietic neoplasms by Flow cytometry has envisaged the utility vista of this technique. This review is aimed at providing an insight into the applications of flow cytometry in pediatric malignancies.